Research Report on Dengue - Pipeline Review, H2 2015 - PowerPoint PPT Presentation

About This Presentation
Title:

Research Report on Dengue - Pipeline Review, H2 2015

Description:

Bharat Book Bureau provides the report, on “ Research Report on Dengue - Pipeline Review, H2 2015” report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from , Company/University websites, SEC filings, investor presentations and featured press releases – PowerPoint PPT presentation

Number of Views:7
Slides: 8
Provided by: bharatbookseo
Category:

less

Transcript and Presenter's Notes

Title: Research Report on Dengue - Pipeline Review, H2 2015


1
Research Report on Dengue - Pipeline Review,
H2 2015
2
Summary
Global Markets Directs, Dengue - Pipeline
Review, H2 2015, provides an overview of the
Dengues therapeutic pipeline. This report
provides comprehensive information on the
therapeutic development for Dengue, complete with
comparative analysis at various stages,
therapeutics assessment by drug target, mechanism
of action (MoA), route of administration (RoA)
and molecule type, along with latest updates, and
featured news and press releases. It also reviews
key players involved in the therapeutic
development for Dengue and special features on
late-stage and discontinued projects. Global
Markets Directs report features investigational
drugs from across globe covering over 20 therapy
areas and nearly 3,000 indications.
3

The report is built using data and information
sourced from Global Markets Directs proprietary
databases, Company/University websites, SEC
filings, investor presentations and featured
press releases from company/university sites and
industry-specific third party sources, put
together by Global Markets Directs team. Drug
profiles/records featured in the report undergoes
periodic updation following a stringent set of
processes that ensures that all the profiles are
updated with the latest set of information.
Additionally, processes including live news
deals tracking, browser based alert-box and
clinical trials registries tracking ensure that
the most recent developments are captured on a
real time basis. The report enhances decision
making capabilities and help to create effective
counter strategies to gain competitive advantage.
It strengthens RD pipelines by identifying new
targets and MOAs to produce first-in-class and
best-in-class products.
s.
4

Note Certain sections in the report may be
removed or altered based on the availability and
relevance of data for the indicated
disease. Scope -The report provides a snapshot
of the global therapeutic landscape of DengueThe
report reviews key pipeline products under drug
profile section which includes, product
description, MoA and RD brief, licensing and
collaboration details other developmental
activities -The report reviews key players
involved in the therapeutics development for
Dengue and enlists all their major and minor
projects -The report summarizes all the dormant
and discontinued pipeline projects -A review of
the Dengue products under development by
companies and universities/research institutes
based on information derived from company and
industry-specific sources. -Pipeline products
coverage based on various stages of development
ranging from pre- registration till discovery and
undisclosed stages.
s.
5

-A detailed assessment of monotherapy and
combination therapy pipeline projects -Coverage
of the Dengue pipeline on the basis of target,
MoA, route of administration and molecule
type -Latest news and deals relating related to
pipeline products Reasons to Buy -Provides
strategically significant competitor information,
analysis, and insights to formulate effective RD
development strategies -Identify emerging players
with potentially strong product portfolio and
create effective counter-strategies to gain
competitive advantage -Develop strategic
initiatives by understanding the focus areas of
leading companies -Identify and understand
important and diverse types of therapeutics under
development for Dengue Plan mergers and
acquisitions effectively by identifying key
players of the most promising pipeline -Devise
corrective measures for pipeline projects by
understanding Dengue pipeline depth and focus of
Indication therapeutics.
s.
6
Table of Contents
  • Global Markets Direct Report Coverage 8
  • Dengue Overview 9
  • Therapeutics Development 10
  • Pipeline Products for Dengue - Overview 10
  • Pipeline Products for Dengue - Comparative
    Analysis 11
  • Dengue - Therapeutics under Development by
    Companies 12
  • Clinical Stage Products 20
  • Dengue - Products under Development by Companies
    22

7
To view the full Executive Summary and Table
of Contents, please visit Research Report on
Dengue - Pipeline Review, H2 2015 Contact
Us- Phone 91-22-27810772/73 Email id
info_at_bharatbook.com Website www.bharatbook.com
Our Blog https//www.bharatbook.com/blog/

Write a Comment
User Comments (0)
About PowerShow.com